Loading...
Entry LevelFull-time
Salary Range
$25,500 - $34,500 /year
This salary is estimated based on similar roles. The actual salary may vary.
The Finance Analyst, International HQ Finance, will support financial planning, reporting, and business process improvement initiatives across the organization. This role will play a key part in advancing automation and driving process efficiencies through innovative use of technology. The ideal candidate will combine strong financial acumen, analytical capability, and technical expertise to help streamline processes, enhance reporting, and support business decision-making.
Responsibilities
• Support financial planning, forecasting, reporting, and analysis activities for International HQ Finance.
• Identify opportunities for automation and process streamlining across finance workflows and reporting activities.
• Drive process efficiencies through innovative use of technology, including development of enhanced tools, dashboards, and reporting solutions.
• Partner with cross-functional stakeholders to improve financial processes, data quality, and reporting accuracy.
• Develop, maintain, and enhance Models (including Forecast Horizon) and Power BI dashboards to support financial insights and decision-making.
• Assist in standardizing finance processes and implementing best practices to improve operational effectiveness.
• Support continuous improvement initiatives aligned with organizational priorities and finance transformation goals including LRP Simplification Project.
Free to sign up. Takes 30 seconds.
About Abbvie
Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.
